Chemkart India holds 7th AGM, approves FY26 financials and auditor appointments

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Chemkart India held its 7th AGM on September 19, 2026 via video conferencing
  • Shareholders approved the adoption of annual audited financial statements for FY26
  • Statutory and secretarial auditors were appointed until the conclusion of the 12th AGM
  • Mr Shailesh Vinodrai Mehta was reappointed as a director retiring by rotation
  • Electronic voting was facilitated by Bigshare Services Private Limited
powered bylight_fuzz_icon
51349314

*this image is generated using AI for illustrative purposes only.

Chemkart India Limited held its seventh annual general meeting on Saturday, September 19, 2026. The meeting was conducted through video conferencing and other audio-visual means, commencing at 12:00 pm and concluding at 12:34 pm.

The company confirmed that the requisite quorum under Section 103 of the Companies Act, 2013 was present. Mr Shailesh Vinodrai Mehta served as the chairperson for the proceedings. Mr Mohammad Asim Siddiqui, Chief Financial Officer, presented the yearly overview and business affairs of the company to the shareholders.

Agenda Items

Shareholders transacted several items of business during the meeting. The agenda included both ordinary and special business items.

Item No Details of the Agenda Type of Resolution
1 Adoption of the annual audited financial statements and reports thereon Ordinary
2 Appointment of Mr Shailesh Vinodrai Mehta as a director retiring by rotation Ordinary
3 Appointment of statutory auditors till the conclusion of the 12th AGM and fixation of remuneration Ordinary
4 Appointment of secretarial auditor till the conclusion of the 12th AGM and fixation of remuneration Ordinary

Voting and Participation

The company facilitated electronic voting for all members through Bigshare Services Private Limited. Members could cast their votes via remote e-voting or during the meeting. CS Nirmal Tiwari, a practicing company secretary based in Mumbai, was appointed as the scrutinizer to oversee the e-voting process.

Two shareholders registered as speaker shareholders were provided specific links to participate in the discussion. Their queries and comments were addressed by the chief financial officer. The facility to appoint proxies was not available at this meeting, although body corporate shareholders could appoint authorized representatives.

The voting results along with the scrutinizer's report will be submitted in due course.

Historical Stock Returns for Chemkart

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+15.71%-1.02%+99.72%-1.98%-23.49%

How might the adoption of the audited financial statements influence Chemkart's valuation and investor sentiment in the upcoming quarters?

What strategic initiatives is Chemkart expected to prioritize following the reappointment of Mr. Shailesh Vinodrai Mehta as a director?

Could the appointment of new statutory and secretarial auditors signal any anticipated changes in corporate governance or compliance standards for the company?

Chemkart invests ₹1.30 crore in subsidiary Easy Raw Materials

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Chemkart invests ₹1.30 crore in subsidiary Easy Raw Materials via rights issue
  • Subsidiary reports nil turnover with net worth of ₹578.60 lakh as on March 31, 2026
  • Funds utilized for commissioning manufacturing unit per IPO prospectus
powered bylight_fuzz_icon
51093322

*this image is generated using AI for illustrative purposes only.

Chemkart India Limited has invested ₹1.30 crore in its wholly owned subsidiary, Easy Raw Materials Private Limited, through a rights issue. The transaction involves the allotment of 13,00,000 equity shares at face value.

The investment aligns with the utilization of proceeds specified in the company’s Initial Public Offer prospectus dated July 10, 2025. The funds are designated for commissioning the manufacturing unit of the subsidiary.

Transaction Details

Chemkart acquired the shares at an issue price of ₹10 per equity share, matching the face value. This brings the total consideration to ₹1.30 crore. The company held 100% of the subsidiary’s shares both before and after this allotment.

Metric Details
Target Entity Easy Raw Materials Private Limited
Investment Amount ₹1.30 crore
Shares Allotted 13,00,000 Equity Shares
Issue Price ₹10 per share
Shareholding Post-Allotment 100%

Subsidiary Financial Position

Easy Raw Materials Private Limited operates in the trading of pharma products and nutritional supplements. Incorporated in 2020, the entity reported nil turnover for the last three years. As on March 31, 2026, the subsidiary recorded a loss after tax of ₹59.47 lakh against a net worth of ₹578.60 lakh.

The paid-up share capital of the subsidiary stands at ₹9.81 crore, divided into 98,10,000 equity shares of ₹10 each. The authorized share capital is ₹10 crore.

Regulatory Compliance

The transaction falls under related-party transactions as per SEBI regulations. Chemkart disclosed the investment under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated the transaction was conducted at arm’s length. No governmental or regulatory approvals were required for this acquisition.

Historical Stock Returns for Chemkart

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+15.71%-1.02%+99.72%-1.98%-23.49%

How will the commissioning of Easy Raw Materials' manufacturing unit impact Chemkart's vertical integration strategy and supply chain resilience?

What is the projected timeline for Easy Raw Materials to transition from nil turnover to generating significant revenue post-commissioning?

Will Chemkart need to inject additional capital beyond the ₹1.30 crore to cover operational costs and working capital requirements for the new facility?

More News on Chemkart

1 Year Returns:-1.98%